EDGAR Filing Documents for 0001193125-10-042893

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-10-042893

Filing Date

2010-02-26

Accepted

2010-02-26 16:07:51

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	2171772
2	REVISED DIRECTOR COMPENSATION POLICY	dex1020.htm	EX-10.20	11714
3	FORM OF EQUITY/LONG-TERM INCENTIVE AWARD AGREEMENT FOR DIRECTORS	dex1022.htm	EX-10.22	29534
4	FORM OF EQUITY/LONG-TERM INCENTIVE AWARD AGREEMENT FOR EMPLOYEES	dex1023.htm	EX-10.23	29719
5	STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES	dex121.htm	EX-12.1	18589
6	SUBSIDIARIES OF THE REGISTRANT	dex211.htm	EX-21.1	986
7	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	1642
8	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex311.htm	EX-31.1	7132
9	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex312.htm	EX-31.2	7410
10	CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER	dex32.htm	EX-32	6292
11	GRAPHIC	g59505g82a40.jpg	GRAPHIC	62374
	Complete submission text file	0001193125-10-042893.txt		2372295

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)